AVENUE SOLUTIONS

Lobbying for ILLUMINA, INC. · Sequencing and array-based solutions for genetic research, clinical and applied markets

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026

Trade (domestic/foreign)

General trade issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.